AUTL
Autolus Therapeutics plc (AUTL) Reports Q4 Earnings
Autolus Therapeutics plc (AUTL) posted Q4 2025 Basic and diluted net loss per ordinary share EPS of -$0.34.
Autolus Therapeutics PLC (AUTL) Q2 2022 earnings call
Autolus Therapeutics PLC (NASDAQ: AUTL) Q2 2022 Earnings Conference
Autolus Therapeutics PLC (AUTL) Q1 2022
Autolus Therapeutics PLC (NASDAQ: AUTL) Q1 2022 Earnings Conference
Autolus Therapeutics PLC (AUTL) Autolus Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on March 10
Autolus Therapeutics PLC (NASDAQ: AUTL) Q4 2021 Earnings Conference
Autolus Therapeutics PLC (AUTL) Financial results for the Third Quarter 2021 – conference call
Autolus Therapeutics PLC (NASDAQ: AUTL) Q3 2021 Earnings Conference
Autolus Therapeutics PLC (AUTL) Autolus Therapeutics to Report Second Quarter 2021 Financial Results on August 5, 2021, and will Participate in the William Blair Biotech Focus Conference 2021 on July 14, 2021
Autolus Therapeutics PLC (NASDAQ: AUTL) Q2 2021 Earnings Conference
Autolus Therapeutics PLC (AUTL) Q4 2020 Earnings Call
Autolus Therapeutics PLC (NASDAQ: AUTL) Q4 2020 Earnings Conference